CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise

RegulatoryapprovedLISRAYAPositive
AI Analysis

Summary

Roivant Sciences received FDA approval for LISRAYA in the treatment of dermatomyositis, leading to an increase in share price.

Importance:9/10
Sentiment:
0.80
FDA approvalLISRAYAdermatomyositisregulatory win
Related Companies

Read the original article

Published by yahoo_finance on August 27, 2026 7:58 PM

Read Original